ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b)

What was recalled

The U.S. Food and Drug Administration (FDA) has issued a Class II recall involving specific batches of Levothyroxine Sodium Tablets, USP, manufactured by Accord Healthcare, Inc. This medication is widely prescribed to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. The specific product under scrutiny is the 200 mcg (0.2 mg) strength tablet. It is important to note that this recall targets two distinct packaging formats distributed nationwide within the United States. The first format consists of 90-count bottles identified by National Drug Code (NDC) 16729-457-15. The second format includes larger, bulk 1000-count bottles bearing NDC 16729-457-17. Both types are classified as prescription-only medications.

To accurately identify whether your supply is part of this recall, you must look closely at the lot numbers and expiration dates printed on the bottle labels. For the 90-count bottles (NDC 16729-457-15), the affected lots are D2402430 and D2402431, both of which carry an expiration date of October 31, 2026. For the 1000-count bottles (NDC 16729-457-17), two separate lot numbers are implicated: D2402432 with an expiration date of October 31, 2026, and D2500180, which expires on December 31, 2026. These tablets were manufactured by Intas Pharmaceuticals Limited, located in Selaqui, Dehradun, India, for Accord Healthcare, Inc., based in Raleigh, North Carolina. The recall was officially initiated on August 6, 2026, covering distribution across all states.

Levothyroxine is a critical hormone replacement therapy, meaning its dosage precision is vital for patient health. The inclusion of both small retail bottles and large institutional or pharmacy bulk containers in this recall highlights the broad reach of the distribution pattern. Consumers should check their current medication against the specific lot numbers listed above. If your bottle matches any of these identifiers, it falls within the scope of the FDA's safety action.

• Product: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg)
• Packaging A: 90-count bottles, NDC 16729-457-15
• Packaging B: 1000-count bottles, NDC 16729-457-17
• Affected Lots (90-count): D2402430, D2402431 (Exp: 10/31/2026)
• Affected Lots (1000-count): D2402432 (Exp: 10/31/2026), D2500180 (Exp: 12/31/2026)
• Manufacturer: Intas Pharmaceuticals Limited (for Accord Healthcare, Inc.)
• Recall Date: August 6, 2026

The hazard, explained

In this specific recall, the core issue is described as a "subpotent drug." To understand what this means for your health, it helps to look at how Levothyroxine Sodium works in the body and what happens when the dosage is lower than intended. Levothyroxine is a synthetic version of thyroxine (T4), a hormone naturally produced by your thyroid gland. This hormone is essentially the master regulator of your metabolism. It controls how quickly your body uses energy, makes proteins, and regulates your sensitivity to other hormones. Because it plays such a critical role in keeping your metabolic engine running correctly, even small deviations in dosage can have significant physiological consequences.

When a drug is classified as subpotent, it means that the amount of active ingredient in each tablet is less than what is stated on the label. In the case of these Accord Healthcare tablets, while the packaging claims each pill contains 200 mcg (0.2 mg) of Levothyroxine Sodium, laboratory testing or quality assurance checks determined that the actual content is lower. This is not a matter of the tablet being broken or worn out; it is a manufacturing inconsistency where the chemical mixture did not meet the strict potency specifications required for a Class II drug recall. The physical mechanism of harm here is biochemical under-dosing. Your body receives less hormone than it expects, creating a gap between what your tissues need and what they get.

For most people taking Levothyroxine, this medication is not optional; it is a lifelong requirement to manage hypothyroidism, a condition where the thyroid gland fails to produce enough hormones on its own. When you are under-dosed, you effectively slip back into a state of hypothyroidism, regardless of your previous stability. The symptoms of this hormonal deficit can be subtle at first but often escalate over time. You might notice an unusual fatigue that sleep doesn't fix, a feeling of being constantly cold when others are comfortable, unexplained weight gain despite no change in diet, or brain fog that affects your ability to concentrate and work.

The danger extends beyond just feeling tired. Thyroid hormones are vital for heart function, cholesterol management, and overall cellular health. Long-term subpotency can lead to elevated cholesterol levels, which increases the risk of cardiovascular issues over time. In more severe cases, if the under-dosing is significant or prolonged, it can contribute to heart enlargement or fluid buildup around the heart (pericardial effusion). While this specific recall does not currently list any reported incidents of injury, the potential for harm exists because the medication is failing to perform its primary job: maintaining your metabolic balance. The "Class II" classification from the FDA indicates that use of this product might cause temporary health problems or pose a slight threat of a serious nature, underscoring why identifying and addressing this potency issue is important for your long-term well-being.

Who is most at risk

When discussing a recall involving Levothyroxine Sodium, specifically the subpotent batches distributed by Accord Healthcare, it is important to first clarify who actually takes this medication. This drug is not typically used for acute conditions or occasional discomfort; rather, it is a daily, lifelong requirement for individuals with hypothyroidism—an condition where the thyroid gland does not produce enough of the essential hormone thyroxine (T4). Consequently, the primary group at risk consists of adults who rely on this medication to regulate their metabolism, heart rate, body temperature, and energy levels. While the recall notice specifies that these are prescription-only drugs manufactured for Accord Healthcare, the end users are patients across the United States who have been prescribed Levothyroxine to manage chronic thyroid conditions.

The specific hazard here is that the drug is "subpotent," meaning it contains less of the active ingredient than labeled. For many people, missing a vitamin supplement or taking a slightly weaker dose of a common pain reliever might result in minor inconvenience or no noticeable effect at all. However, for thyroid patients, even small deviations in hormone levels can have significant and rapid physiological consequences. The risk is not necessarily immediate toxicity, but rather the insidious return of hypothyroid symptoms due to under-medication. Patients who are sensitive to dosage changes, such as the elderly, those with pre-existing heart conditions, or individuals who have recently had their dosage adjusted, are particularly vulnerable. For them, a subpotent tablet can lead to fatigue, weight gain, depression, and in severe cases, cardiac issues, because their bodies are not receiving the precise chemical support they need to function correctly.

It is also crucial to note that Levothyroxine has a very narrow therapeutic index. This means there is only a small range between the dose that treats the condition effectively and a dose that is too low to be effective or potentially too high to cause side effects. Because of this narrow window, patients are at higher risk when any variation in potency occurs. While the recall does not list specific incidents of injury, the nature of the product dictates that anyone depending on a consistent 200 mcg dose for thyroid management is potentially affected. It is less likely to pose a direct danger to children or infants unless they are specifically prescribed this exact strength (which is uncommon, as pediatric doses are typically much lower and compounded differently), but it remains a critical concern for the adult population managing long-term endocrine health.

Additionally, individuals who may not realize their medication has been recalled are at risk simply by remaining unaware. If a patient continues to take the subpotent tablets without switching to an alternative source or consulting their provider, they may experience a gradual decline in health that is difficult to pinpoint as drug-related. Therefore, the most at-risk group includes anyone who was prescribed Levothyroxine Sodium 200 mcg by Accord Healthcare during the relevant distribution period and has not yet verified their bottle’s lot number against the FDA’s recall list.

How to tell if you have the recalled item

• NDC 16729-457-15: This code corresponds to the 90-count bottles.
• NDC 16729-457-17: This code corresponds to the 1000-count bottles.

• Lot # D2402430: Expiration Date 10/31/2026
• Lot # D2402431: Expiration Date 10/31/2026
• Lot # D2402432: Expiration Date 10/31/2026
• Lot # D2500180: Expiration Date 12/31/2026

What to do — step by step

If you currently possess any of the recalled Levothyroxine Sodium Tablets manufactured by Accord Healthcare, Inc., your immediate priority should be ensuring your health and safety while navigating the logistics of the recall. Because this is a prescription medication used to treat thyroid conditions, managing the situation requires a careful balance of stopping exposure to the potentially subpotent product and maintaining continuity of care. Please follow these steps in order.

1. Do not stop taking your medication abruptly without consulting your doctor first. While the recall is due to the drug being "subpotent" (meaning it may contain less of the active ingredient than labeled), suddenly stopping thyroid medication can lead to a rapid return of hypothyroidism symptoms, such as extreme fatigue, weight gain, and heart issues. However, you must recognize that the recalled doses are unreliable. Contact your prescribing physician or pharmacist immediately to inform them that you have this specific lot number. They will advise you on how to transition to a new prescription from a different manufacturer or lot safely. Do not simply throw the medication away yet, as you may need it for identification purposes.

2. Verify your bottle details against the recall list. To confirm if your medication is part of this specific FDA Class II recall, check the label on your bottle carefully. You are looking for Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), manufactured by Accord Healthcare, Inc. Specifically, check the National Drug Code (NDC) and the Lot Number. The recalled items include:

• 90-count bottles with NDC 16729-457-15, bearing Lot numbers D2402430 or D2402431.
• 1000-count bottles with NDC 16729-457-17, bearing Lot numbers D2402432, D2500180.

If your bottle matches these codes and lot numbers, it is definitely part of the recall. If you have other strengths or lot numbers, they are not included in this specific action.

3. Contact your pharmacy or retailer for next steps. Since the FDA recall information does not explicitly state a direct remedy such as a refund process or a mail-back program from Accord Healthcare, Inc., your best course of action is to return the product to the point of purchase. Call the pharmacy where you filled the prescription and explain that you have a recalled Class II drug. They can often cancel the charge for the defective product and help you obtain a replacement from a different supply chain quickly. If you bought it over the counter or through a mail-order service, contact their customer support to inquire about their specific return and refund policy for this lot.

4. Dispose of the medication properly if instructed to do so. If your doctor advises you to stop taking the recalled lots immediately and you cannot get a replacement right away, do not flush the pills down the toilet. Instead, take them to a local drug take-back location or follow the FDA’s guidelines for home disposal (mixing with an unpalatable substance like coffee grounds or cat litter in a sealed bag). Ensure that the medication is inaccessible to children, pets, or anyone else who might accidentally consume it.

5. Monitor your health closely. Because the drug may be subpotent, you might not receive the full therapeutic dose you expect. Be vigilant for any return of hypothyroid symptoms, such as unusual tiredness, cold intolerance, or mood changes. If these symptoms worsen significantly, seek medical attention promptly and bring the bottle with you so your provider can verify the lot number.

Your refund, repair, or replacement options

When you receive a notification about a drug recall, especially one involving a medication like levothyroxine that is critical for managing thyroid function, the immediate question is often, "What happens next?" In this specific instance involving Accord Healthcare, Inc., the official FDA recall documentation does not explicitly state the standard remedy options such as a full refund, a direct replacement with a safe batch, or a repair process. This absence of stated terms in the public record can understandably cause confusion and anxiety. It is important to understand that while the general expectation for drug recalls often involves the manufacturer covering the cost of returning the product or providing an equivalent substitute, you cannot assume these standard procedures apply here without direct confirmation from the responsible parties.

The recall notice identifies Accord Healthcare, Inc., located in Raleigh, North Carolina, as the entity responsible for this distribution. Since the official text does not list a specific customer service hotline, return address, or online portal for claims, you must take proactive steps to locate these details yourself. Typically, this information is found on the original packaging, the prescription label provided by your pharmacy, or on the manufacturer’s official website under their "Product Safety" or "Recall" sections. Do not rely solely on the text of the recall summary you may have received via email or news alert; those summaries are often abbreviated for clarity and speed, omitting the logistical details required to actually process a return.

If you possess one of the affected lots—specifically Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg) with NDCs 16729-457-15 or 16729-457-17 and lot numbers D2402430, D2402431, D2402432, or D2500180—your first step should be to contact your pharmacy. Pharmacists are the primary interface between patients and manufacturers. They can often access internal recall databases that contain more detailed instructions than public FDA announcements. They may already have instructions from Accord Healthcare regarding how to handle returns for reimbursement or credit. If your pharmacy does not have specific guidance, you should reach out to Accord Healthcare’s customer care directly. Look for the contact information printed on the bottle itself or visit their official corporate website to find a general inquiry line.

It is also worth noting that because this recall is classified as a Class II recall by the FDA, it indicates a situation where use of the product might cause temporary or medically reversible health problems, rather than serious permanent harm. However, "subpotent" means the drug may not be delivering the full dose you need. Therefore, your immediate priority should not just be the financial remedy, but ensuring you have uninterrupted access to properly dosed medication. Do not attempt to process a refund or return until you have confirmed with your healthcare provider that you have an alternative source for your levothyroxine. The financial aspect of the recall is secondary to your health continuity. If the manufacturer does not respond promptly or if you cannot find clear instructions, you may need to file a complaint directly with the FDA’s MedWatch program, which can sometimes help facilitate communication between consumers and manufacturers during complex recall situations.

In summary, while a standard refund or replacement process is the norm in many drug recalls, it is not explicitly defined in the available facts for this specific Accord Healthcare batch. You must investigate the packaging and contact the pharmacy or manufacturer directly to uncover the specific steps for reimbursement. Until you receive those instructions, prioritize securing your medication supply from a different source to avoid any gaps in your thyroid treatment.

What can happen if you ignore it

When a medication like levothyroxine is recalled for being subpotent, the immediate reaction might be to simply keep taking what you have until it expires or you run out. This is understandable, as running to the pharmacy can be stressful and time-consuming. However, ignoring this specific type of recall carries significant health risks that go beyond a simple inconvenience. Levothyroxine is not a standard pain reliever or vitamin; it is a hormone replacement therapy that mimics thyroxine (T4), a critical hormone produced by your thyroid gland. This hormone acts as the master regulator for your metabolism, influencing how your body uses energy, how fast your heart beats, and even how your brain functions.

Because the recalled Accord Healthcare tablets are subpotent, they contain less of the active ingredient than the label claims. For someone with a delicate hormonal balance, even a small reduction in dosage can be clinically significant. If you continue to use these tablets, your body may not receive enough thyroid hormone to function properly. This state is known as hypothyroidism. Over time, this deficiency does not just cause temporary fatigue; it can lead to a systemic slowdown of your bodily processes. You might notice symptoms such as unexplained weight gain, extreme sensitivity to cold, constipation, dry skin, hair loss, and a slowed heart rate (bradycardia). These are not merely minor annoyances; they are signs that your body’s engine is running without the correct fuel.

The danger becomes more acute for individuals with pre-existing heart conditions. Thyroid hormone levels have a direct and powerful effect on cardiovascular health. Too little thyroid hormone can cause changes in cholesterol levels, increasing the risk of high LDL (bad) cholesterol, which puts additional strain on your heart. In severe cases, untreated hypothyroidism can lead to pericardial effusion, where fluid builds up around the heart, or exacerbate existing heart failure. For elderly patients or those with coronary artery disease, this added stress on the cardiovascular system is particularly dangerous.

Furthermore, if you are taking levothyroxine for thyroid cancer suppression, subpotent doses can have even more serious implications. In these cases, the goal is often to keep Thyroid Stimulating Hormone (TSH) levels very low to prevent cancer recurrence. If your medication is weaker than expected, your TSH levels may rise, potentially allowing any remaining cancer cells to grow or become active. This underscores why consistency in dosage is not just about feeling better today; it is about long-term disease management and prevention.

Finally, consider the unpredictability of switching medications. If you are currently stable on a specific dose from another manufacturer and suddenly switch to this subpotent version without medical supervision, your body will undergo an abrupt change in hormone exposure. This can lead to a "crash" in your metabolic rate, leaving you feeling debilitated, depressed, or cognitively foggy. While the FDA recall notice does not report specific injuries from these tablets, the nature of subpotent drugs means that harm is often cumulative and silent until it becomes clinically significant. Ignoring the recall leaves your health management to chance, rather than ensuring you receive the precise care your body requires.

Staying safe: broader tips

While specific product recalls are necessary reminders of the complexities involved in global supply chains and pharmaceutical manufacturing, maintaining your personal health safety largely depends on consistent, proactive habits. When it comes to prescription medications like levothyroxine, which is critical for regulating metabolism and energy levels, the most powerful tool you have is open communication with your healthcare provider. Never adjust your dosage or stop taking a medication because you are worried about a potential recall. Instead, contact your pharmacist or doctor immediately. They have access to real-time data from the FDA and can verify whether your specific prescription is affected. If it is, they will guide you through the process of obtaining a replacement that meets current quality standards, ensuring there is no gap in your treatment.

It is also wise to establish a routine for reviewing official safety updates. The U.S. Food and Drug Administration (FDA) maintains a public database where recall announcements are posted. You do not need to check this daily, but making it a habit to review these updates once a month, or when you refill a long-term prescription, can provide peace of mind. Many people find it helpful to sign up for email alerts from the FDA or to follow reputable health news sources that summarize regulatory actions in plain language. This helps you stay informed without becoming overwhelmed by the sheer volume of information available online.

Another important aspect of medication safety is proper storage and handling at home. Even if a drug has not been recalled, environmental factors can degrade its potency over time. For many medications, including thyroid hormones, extreme temperatures and humidity can alter their chemical structure. Keep your prescriptions in a cool, dry place away from direct sunlight, such as a bedroom closet or a high shelf in a bathroom that does not get steamy during showers. Avoid storing them in the car or in humid bathrooms unless the product label explicitly permits it. Check the expiration dates regularly and dispose of any outdated medications safely through local pharmacy take-back programs.

Finally, consider keeping a personal medication log. Write down the brand name, manufacturer, lot number, and expiration date of your prescriptions when you first receive them. This simple practice not only helps you track your inventory but also makes it significantly easier to respond quickly if a recall is announced. By staying organized and maintaining a collaborative relationship with your healthcare team, you transform potential anxiety about product safety into confident, informed management of your health.